The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer

Completed

• Conditions: Counseling; Breast Cancer
• Interventions: Behavioral: focus group & questionaire

• Registration Number: NCT00588705
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this study is to first understand how MSKCC Clinical Genetics Service doctors talk to women with breast cancer about any genetic risks they might carry, and if they help women to think about what they might say, in turn, to their relatives, especially their daughters.

A second part of the study asks women for their opinions about when and how their daughters should be told about any genetic risks.

All of this will help us develop teaching methods to help our doctors improve the way they talk about genetic risk when women with breast cancer have adolescent daughters.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-12
• Study First Submitted: 2007-12-24
• Study First Submitted QC: 2008-01-07
• Study First Posted: 2008-01-08
• Status Verified: 2017-01
• Primary Completion: 2017-01
• Study Completion: 2017-01
• Last Update Submitted: 2017-01-27
• Last Update Posted: 2017-01-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 27

Inclusion Criteria

• Women seen in the MSK CGS Service who have a diagnosis of breast cancer or
• a family history of breast cancer and
• have biological daughter(s) in the age range 12-20 years will be eligible to participate in Phase I & II.
• Women who were consented to Phase I will automatically be eligible for Phase II.

Read More

Exclusion Criteria

• Women seen in the MSK CGS Service will be ineligible if they have no diagnosis of breast cancer and no family history of breast cancer,
• do not have a biological daughter,
• or have a biological daughter fewer than 12 or greater than 20 years(unless they were consented to Phase 1).
• Women will be ineligible if they are not English speaking,
• have intellectual or cognitive impairment,
• or active mental illness rendering them incapable of giving informed consent, such as might occur with active psychosis.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
focus group & questionaire	focus group & questionaire	The group will discuss its views about how and when to talk about the risk of getting breast cancer. The focus group will be video recorded and the video recorded material will be later transcribed and carefully analyzed. In addition you will be asked to answer questions about yourself, such as education and marital status.

Primary Outcome Measures

Name	Time	Method
Is a demonstration of the effectiveness of the module in changing the behavior of clinicians after taking part in the communication skills module.	conclusion of study

Secondary Outcome Measures

Name	Time	Method
To examine the views of women about the provision of genetic risk information to their daughters.	conclusion of study

Trial Locations

Locations (1)

Memorial Sloan-Kettering Cancer Center; 🇺🇸 New York, New York, United States